Concord Biotech has announced that Chief Financial Officer Lalit Sethi will be retiring early due to personal reasons. His last day will be January 5, 2026. Mr. Sethi has assured a smooth transition, and the company has already closed the trading window for its securities. The announcement was made on December 8, 2025.
CFO Retirement Announcement
Lalit Sethi, Chief Financial Officer (CFO) of Concord Biotech, has announced his intention to retire early, effective at the close of business hours on January 5, 2026. The decision is driven by personal reasons.
Smooth Transition Assured
Mr. Sethi has committed to ensuring a seamless transition, including a complete handover of financial statements, compliance documentation, regulatory files, and investor relations materials. He also expressed his confidence in the company’s leadership and strategic direction. He is approaching age 59.
Trading Window Closure
The trading window for dealing in the company’s securities has been closed from December 8, 2025, and will remain closed for 48 hours following the announcement of his retirement.
Source: BSE
